AKT1 and B-cell chronic lymphocytic leukemia: showed that CLL cells required elevated levels of miR-22 expression for effective proliferation, with miR-22 leading to decreased PTEN and increased PI3K-AKT signalling, particularly in poor prognostic patient cohorts.